Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,762,467
+$901,297 QoQ
Shares Held
43,150
+12.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#225
of 1,598 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MAI Capital Management holds $587,268,758 across 14 Drug Manufacturers - General names. NVS ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
616,940 | $155,246,781 | |
| 2 | LLY |
ELI LILLY & Co
|
127,320 | $152,711,440 | |
| 3 | JNJ |
Johnson & Johnson
|
548,420 | $139,282,227 | |
| 4 | MRK |
Merck & Co., Inc.
|
380,217 | $48,857,884 | |
| 5 | AMGN |
Amgen Inc
|
100,869 | $36,526,682 | |
| 6 | PFE |
Pfizer Inc
|
614,061 | $14,786,588 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
247,151 | $14,240,840 | |
| 8 | NVS |
Novartis AG
This page
|
43,150 | $6,762,467 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,762,467 | 43,150 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,861,170 | 38,371 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,264,565 | 38,185 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,820,013 | 29,788 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,963,897 | 24,493 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,504,732 | 22,468 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,341,375 | 24,061 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,023,086 | 17,589 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,913,150 | 36,757 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,181,449 | 32,890 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,571,100 | 25,464 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,384,644 | 23,411 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,389,246 | 23,677 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,431,796 | 15,563 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,371,504 | 15,118 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $894,637 | 11,770 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $700,161 | 8,283 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $660,582 | 7,528 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $568,992 | 6,505 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,168,881 | 14,293 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,293,783 | 14,180 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $1,165,605 | 13,636 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,125,983 | 11,924 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,008,996 | 11,603 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,069,915 | 12,250 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $1,042,415 | 12,643 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||